tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Technical Analysis

Compare
124 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Dermata Therapeutics is a Sell.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 0.86, while Dermata Therapeutics’s (DRMA) share price is $0.74, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 1.01, while Dermata Therapeutics’s (DRMA) share price is $0.74, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Apr 28, 2025, 04:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.64
0.69
0.72
0.77
0.80
0.86
0.89
Fibonacci
0.69
0.72
0.74
0.77
0.81
0.83
0.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Apr 28, 2025, 04:20 AM
Period
Simple
Exponential
MA5
0.74Buy
0.75Sell
MA10
0.75Sell
0.77Sell
MA20
0.85Sell
0.86Sell
MA50
1.07Sell
1.01Sell
MA100
1.15Sell
1.19Sell
MA200
1.42Sell
1.66Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 0.77, while Dermata Therapeutics’s (DRMA) share price is $0.74, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 1.19, while Dermata Therapeutics’s (DRMA) share price is $0.74, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $0.74 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 1.07, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $0.74 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 1.15, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $0.74 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 1.42, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Apr 28, 2025, 04:20 AM
Name
Value
Implied Action
RSI (14)
33.99
Neutral
STOCH (9,6)
35.00
Neutral
STOCHRSI (14)
24.24
Neutral
MACD (12,26)
-0.11
Sell
ADX (14)
20.54
Neutral
Williams %R
-82.14
Buy
CCI (14)
-51.81
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
35.19
Neutral
ROC
-22.92
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 33.99, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 20.54, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -51.81, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -22.92, creating a Sell signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Strong Sell.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 33.99, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.11, which suggests DRMA is a Sell.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 0.74, which suggests DRMA is a Buy.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 0.85, which suggests DRMA is a Sell.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 1.07, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 1.42, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -82.14, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is -51.81, which suggests DRMA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis